Patent ID: 11969448
Assignee: GENMONT BIOTECH INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method for improving a side effect of Gemcitabine, comprising a step of administering a probiotic composition comprising an effective amount of Lactobacillus paracasei GMNL-133, an effective amount of Lactobacillus reuteri GMNL-89, and a pharmaceutically acceptable carrier to a subject in need, wherein the side effect is liver inflammation, and the Lactobacillus paracasei GMNL-133 was deposited in the China Center for Type Culture Collection located at Wuhan University, Wuhan 430072 P.R. China on Sep. 26, 2011 under an accession number CCTCC NO. M 2011331 under the Budapest Treaty, and the Lactobacillus reuteri GMNL-89 was deposited in the China Center for Type Culture Collection located at Wuhan University, Wuhan 430072 P.R. China on Nov. 19, 2007 under an accession number CCTCC NO. M 207154 under the Budapest Treaty, wherein a ratio of a number of bacteria of the Lactobacillus paracasei GMNL-133 to a number of bacteria of the Lactobacillus reuteri GMNL-89 is 1:1.